The final inclusion of the speech therapy solution in the DiGA directory was based on the results of a study conducted in collaboration with Ludwig Maximilians University and the University of Applied Sciences and Arts in Göttingen. According to the study, Neolexon’s aphasia app demonstrably helps affected individuals improve their language skills after brain damage such as a stroke. Furthermore, the study showed that using the app improves the emotional health and quality of life of those affected.
Speech therapist and Neolexon co-founder Mona Späth comments:
“We are incredibly happy! Exactly ten years ago, my co-founder Hanna Jakob and I came up with the idea for this app – now it’s clear: Neolexon Aphasia will be permanently reimbursed by all statutory health insurance companies. From the beginning, our goal was to help those affected with digital therapy that is proven to be effective and that can be used by all people with aphasia – regardless of their financial situation. For us, this is the realization of a long-held wish.”
The aphasia app is one of two digital speech therapy solutions with which Neolexon offers fully individualized therapy on tablet or smartphone. Another app is designed for children with impaired language development. The apps support patients alongside treatment with their speech therapists. According to the study results, the average daily usage time of the aphasia app was 31 minutes. Combined with standard therapy on-site, those affected achieved the recommended therapy duration of at least five hours per week. Due to an acute shortage of speech therapy slots, these five hours are often not feasible without digital supplementation.
